|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,059.00 CHF | -1.16% |
|
+2.38% | -2.77% |
| 07:21am | US Drops Antitrust Investigation Against Symrise | RE |
| 05:28am | DSM Firmenich Share Slump Weighs on Symrise and Givaudan | DP |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.22 | 5.98 | 6.32 | 7.53 | 7.13 | |||||
Return on Total Capital | 8.29 | 7.69 | 7.88 | 9.59 | 9.32 | |||||
Return On Equity % | 22.04 | 20.93 | 21.69 | 25.42 | 23.42 | |||||
Return on Common Equity | 22.13 | 20.98 | 21.71 | 25.43 | 23.5 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.71 | 38.81 | 41.16 | 44.13 | 43.52 | |||||
SG&A Margin | 17.43 | 15.62 | 15.98 | 16.49 | 16.54 | |||||
EBITDA Margin % | 20.95 | 19.19 | 20.16 | 22.29 | 21.69 | |||||
EBITA Margin % | 18.66 | 17 | 17.99 | 20.25 | 19.66 | |||||
EBIT Margin % | 16.44 | 15.43 | 16.54 | 18.87 | 18.28 | |||||
Income From Continuing Operations Margin % | 12.28 | 12.03 | 12.91 | 14.71 | 14.33 | |||||
Net Income Margin % | 12.28 | 12.03 | 12.91 | 14.71 | 14.33 | |||||
Net Avail. For Common Margin % | 12.28 | 12.03 | 12.91 | 14.71 | 14.33 | |||||
Normalized Net Income Margin | 9.18 | 8.17 | 9.29 | 11.23 | 10.89 | |||||
Levered Free Cash Flow Margin | 13.32 | 4.76 | 14.72 | 11.93 | 15.13 | |||||
Unlevered Free Cash Flow Margin | 14.11 | 5.57 | 15.72 | 12.85 | 15.98 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.62 | 0.61 | 0.64 | 0.62 | |||||
Fixed Assets Turnover | 2.96 | 3.1 | 3.05 | 3.21 | 3.16 | |||||
Receivables Turnover (Average Receivables) | 4.74 | 4.78 | 4.67 | 4.73 | 4.53 | |||||
Inventory Turnover (Average Inventory) | 2.97 | 3.11 | 3.02 | 3.07 | 2.96 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.47 | 1.88 | 1.75 | 1.49 | 1.74 | |||||
Quick Ratio | 0.84 | 1.12 | 1.09 | 0.93 | 1.1 | |||||
Operating Cash Flow to Current Liabilities | 0.56 | 0.48 | 0.67 | 0.57 | 0.64 | |||||
Days Sales Outstanding (Average Receivables) | 77.08 | 76.31 | 78.23 | 77.33 | 80.53 | |||||
Days Outstanding Inventory (Average Inventory) | 123.02 | 117.46 | 121.01 | 119.32 | 123.25 | |||||
Average Days Payable Outstanding | 82.73 | 77.56 | 81.55 | 85.68 | 100.12 | |||||
Cash Conversion Cycle (Average Days) | 117.36 | 116.22 | 117.69 | 110.97 | 103.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 118.42 | 118.13 | 122.69 | 103.78 | 96.67 | |||||
Total Debt / Total Capital | 54.22 | 54.15 | 55.09 | 50.93 | 49.15 | |||||
LT Debt/Equity | 107.56 | 109.72 | 111.63 | 85.89 | 91.62 | |||||
Long-Term Debt / Total Capital | 49.24 | 50.3 | 50.13 | 42.15 | 46.58 | |||||
Total Liabilities / Total Assets | 65.49 | 63.19 | 64.07 | 62.16 | 61.5 | |||||
EBIT / Interest Expense | 12.35 | 11.56 | 10.04 | 12.27 | 13.13 | |||||
EBITDA / Interest Expense | 16.3 | 14.94 | 12.68 | 14.96 | 16.15 | |||||
(EBITDA - Capex) / Interest Expense | 14.21 | 12.56 | 10.8 | 12.89 | 13.76 | |||||
Total Debt / EBITDA | 3.22 | 3.53 | 3.39 | 2.78 | 2.63 | |||||
Net Debt / EBITDA | 3.03 | 3.18 | 2.97 | 2.34 | 2.19 | |||||
Total Debt / (EBITDA - Capex) | 3.69 | 4.2 | 3.98 | 3.23 | 3.09 | |||||
Net Debt / (EBITDA - Capex) | 3.47 | 3.79 | 3.49 | 2.71 | 2.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.73 | 6.48 | -2.84 | 7.19 | 0.81 | |||||
Gross Profit, 1 Yr. Growth % | 7.37 | -3.26 | 3.04 | 14.93 | -0.58 | |||||
EBITDA, 1 Yr. Growth % | 5.18 | -2.43 | 2.05 | 21.11 | -1.88 | |||||
EBITA, 1 Yr. Growth % | 5.59 | -2.97 | 2.81 | 23.64 | -2.13 | |||||
EBIT, 1 Yr. Growth % | 6.6 | -0.09 | 4.19 | 25.58 | -2.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 10.5 | 4.26 | 4.32 | 22.06 | -1.74 | |||||
Net Income, 1 Yr. Growth % | 10.5 | 4.26 | 4.32 | 22.06 | -1.74 | |||||
Normalized Net Income, 1 Yr. Growth % | 6.74 | -5.3 | 10.54 | 33.47 | -2.25 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 10.52 | 4.68 | 4.28 | 21.93 | -1.84 | |||||
Accounts Receivable, 1 Yr. Growth % | 7.73 | 3.28 | -3.97 | 15.7 | -3.75 | |||||
Inventory, 1 Yr. Growth % | 14.9 | 3.12 | -10.4 | 11.76 | 0 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.11 | -0.35 | -2.22 | 6.29 | -1.43 | |||||
Total Assets, 1 Yr. Growth % | 7.15 | 0.66 | -3.31 | 8.73 | -1.94 | |||||
Tangible Book Value, 1 Yr. Growth % | -12.25 | -55.39 | 12.56 | -46.35 | -26 | |||||
Common Equity, 1 Yr. Growth % | 12.58 | 7.71 | -5.65 | 14.65 | -0.9 | |||||
Cash From Operations, 1 Yr. Growth % | 8.33 | -26.4 | 44.83 | 18.35 | -6.95 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.06 | 21.51 | -4.87 | 9.77 | 5.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 9.75 | -62.06 | 247.5 | -11.5 | 27.89 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 9.59 | -58.11 | 210.35 | -10.85 | 25.34 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.12 | 1.52 | 1.49 | 2.94 | 2.86 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.8 | 6.1 | 1.71 | 2.05 | 3.95 | |||||
Gross Profit, 2 Yr. CAGR % | 6.23 | 1.92 | -0.16 | 8.82 | 6.9 | |||||
EBITDA, 2 Yr. CAGR % | 7.97 | 1.31 | -0.21 | 9.97 | 9.01 | |||||
EBITA, 2 Yr. CAGR % | 8.77 | 1.22 | -0.12 | 11.38 | 10 | |||||
EBIT, 2 Yr. CAGR % | 8.65 | 3.2 | 2.03 | 12.88 | 10.73 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.14 | 7.34 | 4.29 | 12.84 | 9.51 | |||||
Net Income, 2 Yr. CAGR % | 8.14 | 7.34 | 4.29 | 12.84 | 9.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.64 | 0.54 | 2.32 | 19.68 | 14.22 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.12 | 7.56 | 4.48 | 12.76 | 9.4 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.56 | 5.48 | -0.41 | 5.41 | 5.53 | |||||
Inventory, 2 Yr. CAGR % | 9.59 | 8.85 | -3.88 | 0.07 | 5.72 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -0.76 | 1.59 | -1.29 | 1.94 | 2.36 | |||||
Total Assets, 2 Yr. CAGR % | 4.81 | 3.92 | -1.35 | 2.53 | 3.25 | |||||
Tangible Book Value, 2 Yr. CAGR % | 19.6 | -37.3 | -29.14 | -22.29 | -36.99 | |||||
Common Equity, 2 Yr. CAGR % | 3.89 | 10.12 | 0.81 | 4.01 | 6.59 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.48 | -10.71 | 3.25 | 30.92 | 4.94 | |||||
Capital Expenditures, 2 Yr. CAGR % | -17.76 | 9.64 | 7.51 | 2.19 | 7.62 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 15.17 | -35.36 | 6.74 | 73.75 | 6.39 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.93 | -32.14 | 7.2 | 64.9 | 5.71 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.18 | 2.32 | 1.5 | 2.21 | 2.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.54 | 4.69 | 3.03 | 3.51 | 1.64 | |||||
Gross Profit, 3 Yr. CAGR % | 7.02 | 2.97 | 2.29 | 4.64 | 5.59 | |||||
EBITDA, 3 Yr. CAGR % | 9.37 | 4.38 | 1.55 | 5.67 | 5.87 | |||||
EBITA, 3 Yr. CAGR % | 9.76 | 4.71 | 1.75 | 6.37 | 6.68 | |||||
EBIT, 3 Yr. CAGR % | 8.69 | 5.65 | 3.53 | 8.38 | 7.55 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.38 | 6.83 | 6.32 | 9.91 | 7.76 | |||||
Net Income, 3 Yr. CAGR % | 7.38 | 6.83 | 6.32 | 9.91 | 7.76 | |||||
Normalized Net Income, 3 Yr. CAGR % | 8.92 | 3.78 | 3.77 | 10.7 | 11.87 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.39 | 6.96 | 6.46 | 10 | 7.67 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.32 | 3.47 | 2.23 | 4.69 | 2.26 | |||||
Inventory, 3 Yr. CAGR % | 7.92 | 7.39 | 2.01 | 1.08 | 0.05 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.21 | -0.48 | 0.3 | 1.17 | 0.81 | |||||
Total Assets, 3 Yr. CAGR % | 7.17 | 3.45 | 1.45 | 1.9 | 1.02 | |||||
Tangible Book Value, 3 Yr. CAGR % | 45.82 | -13.78 | -23.79 | -35.42 | -23.55 | |||||
Common Equity, 3 Yr. CAGR % | 1.93 | 5.15 | 4.59 | 5.23 | 2.35 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.03 | -5.85 | 4.91 | 8.06 | 16.84 | |||||
Capital Expenditures, 3 Yr. CAGR % | -8.02 | -6.33 | 4.57 | 8.26 | 3.28 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 50.94 | -20.37 | 7.86 | -0.34 | 56.88 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 49.18 | -17.82 | 8.11 | 0.23 | 50.49 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.23 | 2.62 | 2.04 | 1.98 | 2.43 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.47 | 7.1 | 4.58 | 3.63 | 3.4 | |||||
Gross Profit, 5 Yr. CAGR % | 6.05 | 4.19 | 4.09 | 5.27 | 4.11 | |||||
EBITDA, 5 Yr. CAGR % | 7.39 | 5.99 | 5.43 | 6.58 | 4.02 | |||||
EBITA, 5 Yr. CAGR % | 7.54 | 5.93 | 5.7 | 7.33 | 4.46 | |||||
EBIT, 5 Yr. CAGR % | 6.24 | 5.43 | 5.97 | 8.49 | 5.79 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 4.98 | 3.52 | 6.14 | 9.2 | 7.59 | |||||
Net Income, 5 Yr. CAGR % | 4.98 | 3.52 | 6.14 | 9.2 | 7.59 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.02 | 3.55 | 6.23 | 9.87 | 7.19 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 4.97 | 3.59 | 6.22 | 9.25 | 7.62 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.01 | 5.68 | 2.99 | 4.24 | 3.54 | |||||
Inventory, 5 Yr. CAGR % | 11.86 | 9.55 | 3.03 | 4.4 | 3.48 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.7 | 7.75 | 4.97 | 0.49 | 1.12 | |||||
Total Assets, 5 Yr. CAGR % | 11.88 | 9.51 | 3.71 | 3.08 | 2.17 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.21 | -17.08 | 9.35 | -17.29 | -29.38 | |||||
Common Equity, 5 Yr. CAGR % | 3.59 | 3.65 | 1.48 | 4.69 | 5.39 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.86 | 1.94 | 8.43 | 7.42 | 4.92 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.46 | 3.42 | -2.09 | -3.01 | 5.78 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 11.14 | -6.69 | 31.5 | 5.67 | 6.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.32 | -4.42 | 30.79 | 5.93 | 6.77 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.34 | 2.93 | 2.53 | 2.46 | 2.38 |
- Stock Market
- Equities
- GIVN Stock
- Financials Givaudan SA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















